Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
34.25
+2.16 (6.73%)
At close: Jan 7, 2026, 4:00 PM EST
33.59
-0.66 (-1.93%)
After-hours: Jan 7, 2026, 7:38 PM EST
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $1.5 billion as of January 7, 2026.
Market Cap
1.50B
Enterprise Value
1.49B
1-Year Change
n/a
Ranking
Category
Stock Price
$34.25
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $1.50B, an increase of 585.00%. That is a compound annual growth rate of 785.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 1.50B | 13.90% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 992.16B |
| Johnson & Johnson | 499.90B |
| AbbVie | 412.54B |
| UnitedHealth Group | 309.53B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.49B |
| Merck & Co. | 269.55B |
| Novo Nordisk | 254.60B |